Nuvectis Pharma Inc
NVCT7.200USD
+0.400+5.88%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
170.17MMarket Cap
LossP/E TTM
Nuvectis Pharma Inc
7.200
+0.400+5.88%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
4.22%-4.17M
35.97%-2.46M
25.89%-2.40M
26.03%-3.02M
8.77%-4.36M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
---3.52M
---4.42M
---2.54M
---3.08M
Net income from continuing operations
-27.84%-5.33M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
---6.70M
---5.88M
---3.57M
---2.94M
Change in working capital
85.84%-210.00K
70.23%2.64M
-60.77%590.00K
-78.37%146.00K
30.38%-1.48M
-42.48%1.55M
68.23%1.50M
30.81%675.00K
-637.02%-2.13M
--2.70M
--894.00K
--516.00K
---289.00K
-Change in payables and accrued expense
----
----
----
----
----
107.09%160.00K
-6.05%1.37M
6.15%276.00K
-432.47%-1.80M
---2.26M
--1.45M
--260.00K
--542.00K
-Change in other current assets
-9.95%-210.00K
-55.56%64.00K
-68.12%44.00K
-82.96%68.00K
41.77%-191.00K
-82.31%144.00K
124.64%138.00K
55.86%399.00K
60.53%-328.00K
--814.00K
---560.00K
--256.00K
---831.00K
-Change in other current liabilities
---519.00K
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
4.22%-4.17M
35.97%-2.46M
25.89%-2.40M
26.03%-3.02M
8.77%-4.36M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
---3.52M
---4.42M
---2.54M
---3.08M
Investing cash flow
Net cash flow from other investing activities
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
--0.00
----
----
----
----
----
----
--0.00
--0.00
----
----
--0.00
--0.00
Financing cash flow
Cash flow from continuous financing activities
230.17%15.51M
317.56%3.83M
107.25%1.46M
-87.35%1.67M
1763.49%4.70M
800.00%917.00K
-95.15%703.00K
2386.33%13.21M
-98.20%252.00K
---131.00K
--14.49M
---578.00K
--14.03M
Net cash flow from common stock issuance/repurchase
246.42%16.80M
338.73%3.95M
33.84%1.51M
-32.54%1.73M
590.74%4.85M
--901.00K
-92.91%1.13M
--2.56M
-95.61%702.00K
--0.00
--15.88M
--0.00
--16.00M
Proceeds from issuance of warrants
----
----
----
----
----
--0.00
--14.00K
--11.18M
----
----
----
----
----
Net cash flow from other financing activities
-745.10%-1.29M
-875.00%-124.00K
88.56%-50.00K
89.48%-55.00K
66.00%-153.00K
112.21%16.00K
68.49%-437.00K
9.52%-523.00K
77.19%-450.00K
---131.00K
---1.39M
---578.00K
---1.97M
Net cash from non-recurrent financing activities
Net cash from financing activities
230.17%15.51M
317.56%3.83M
107.25%1.46M
-87.35%1.67M
1763.49%4.70M
800.00%917.00K
-95.15%703.00K
2386.33%13.21M
-98.20%252.00K
---131.00K
--14.49M
---578.00K
--14.03M
Net cash flow
Beginning cash balance
-3.10%18.53M
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
-4.34%19.13M
-6.69%22.06M
81.26%24.60M
-7.34%15.47M
248.19%19.99M
--23.64M
--13.57M
--16.69M
--5.74M
Current period cash flow changes
3252.37%11.33M
146.51%1.36M
62.73%-947.00K
-114.76%-1.35M
107.47%338.00K
19.58%-2.93M
-125.24%-2.54M
392.60%9.13M
-141.32%-4.53M
---3.65M
--10.07M
---3.12M
--10.95M
Ending cash balance
53.43%29.86M
-3.10%18.53M
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
-4.34%19.13M
-6.69%22.06M
81.26%24.60M
-7.34%15.47M
--19.99M
--23.64M
--13.57M
--16.69M
Free cash flow
----
----
----
----
----
----
----
----
----
----
----
---2.54M
---3.08M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
